Nurse Practitioner in Prosser, WA Accepting Medicare

7 Nurse Practitioner nurses found. Showing 1 - 7

Zachary Ryan Garland, MSN, ARNP, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 336 Chardonnay Ave Ste A, Prosser, WA 99350 Phone: 509-786-1576

Mr. Jonathon Wayne Blanchard, ARNP, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 336 Chardonnay Ave, Prosser, WA 99350 Phone: 509-786-1576    Fax: 509-786-1574

Selena Diaz, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 355 Chardonnay Ave, Prosser, WA 99350 Phone: 509-781-6366

Heather S Morse, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 336 Chardonnay Ave Ste A, Prosser, WA 99350 Phone: 509-786-1576    Fax: 509-786-1574

Afton Royce Dunham, ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 336 Chardonnay Ave Ste A, Prosser, WA 99350 Phone: 509-786-1576

Samantha Pedersen, RN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 336 Chardonnay Ave Ste A, Prosser, WA 99350 Phone: 509-786-1576

Mrs. Pamela M Morris, A.R.N.P. Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 336 Chardonnay Ave Ste A, Prosser, WA 99350 Phone: 509-786-1576    Fax: 509-786-1574

News Archive

DigiM Solution receives FDA contract for microstructure imaging study

DigiM Solution LLC, a provider of microstructure characterization and optimization solutions and software, has received a contract from the Office of Generic Drugs of the U.S. Food and Drug Administration.

Studies support use of proton radiation therapy to treat patients with fatal type of liver cancer

Two new studies support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma, a common but often fatal type of liver cancer for which there are limited treatment options.

Researchers develop new method to culture norovirus in intestinal cells

Researchers have succeeded in culturing norovirus in human intestinal cells, a breakthrough that could help scientists develop novel therapeutics and vaccines against the debilitating effects of the virus.

ImmunoCellular Therapeutics completes humanization of its ICT-37 and ICT-109 antibody candidates

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has completed humanization of ICT-37 and ICT-109.

Disease-modifying antirheumatic drugs reduce risk of diabetes from RA, psoriasis

In a study that included nearly 14,000 patients with rheumatoid arthritis or psoriasis, the use of certain disease-modifying antirheumatic drugs was found to lower the risk of diabetes, according to a study in the June 22/29 issue of JAMA.

Read more Medical News

› Verified 1 days ago